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Background: Autophagy is an evolutionarily conserved cellular process that involves the lysosomal degradation of
proteins and organelles and the recycling of cellular components to ensure cellular survival under external or internal
stress. Numerous data has indicated that autophagy can be successfully targeted for the treatment of multiple cancers.
We have previously demonstrated that tetrandrine, a bisbenzylisoquinoline alkaloid isolated from the broadly used
Chinese medicinal herb Stephaniae tetrandrae, exhibits potent antitumor effects when used either alone or in
combination with other drugs.
Results: In the present study, we showed that tetrandrine is a broad-spectrum potent autophagy agonist. Although
low-dose tetrandrine treatment does not affect cell viability, it can potently induce autophagy in a variety of cell lines,
including cancerous cells and nontumorigenic cells. The autophagy inhibitors 3-methyladenine (3-MA) and chloroquine
(CQ), effectively blocked tetrandrine-induced autophagy. Moreover, tetrandrine significantly triggered the induction of
mitophagy. The underlying mechanisms are associated with the tetrandrine-induced production of intracellular reactive
oxygen species (ROS), which plays a critical role in tetrandrine-induced autophagy.
Conclusions: Here, we report that tetrandrine is a potent cell autophagy agonist and may have a wide range of
applications in the fields of antitumor therapy and basic scientific research.
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Three types of autophagy have been characterized: macro-
autophagy, microautophagy, and chaperone-mediated au-
tophagy [1]. Macroautophagy (usually referred to simply
as autophagy) is an evolutionarily conserved cellular
process that involves the lysosomal degradation of pro-
teins, organelles and other cellular components and the
recycling of cellular components to ensure cellular sur-
vival when cells experience starvation or other stimuli [2].
Autophagy serves as a temporary survival mechanism that
plays crucial roles in maintaining intercellular homeosta-
sis, remodeling development, and regulating metabolism
and the immune response, and is also associated with vari-
ous human diseases and diverse stresses [3-5]. Ionizing ra-
diation and diverse classes of anticancer agents usually
affect autophagy, causing high levels of autophagosome* Correspondence: lx@whu.edu.cn; whli@whu.edu.cn
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unless otherwise stated.accumulation and/or increasing autophagic flux [6]. The
reported effects of autophagy on cancer therapy appear to
be contradictory: while many studies have suggested that
autophagy induction is a mechanism of chemoresistance,
other investigations have concluded that autophagy is ac-
tually necessary for the antitumor effect of drugs [7-10].
For many drugs, though the role and the molecular mech-
anisms that underlie the effects on autophagy are still un-
clear, they have been widely used in clinical treatment or
clinical trials [6,11]. In this regard, both potent autophagy
agonists and autophagy inhibitors may exhibit potential in
clinical treatment [12,13].
Tetrandrine is one member of the bisbenzylisoquinoline
alkaloids isolated from the root of a traditional Chinese
medicinal herb, Stephaniae tetrandrae, which has been
broadly applied in clinical treatment for thousands of years
in China [14]. In recent decades, it has been used to treat
patients with rheumatoid arthritis [15], hypertension [16],
sepsis [17], inflammation [18,19], occlusive cardiovascular
disorders [20] and silicosis [21] in modern medicine
[22-24]. Due to its action on intracellular multipleThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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even when administered at high doses, tetrandrine has
been attracted considerable attention as an antitumor
therapeutic [25-28]. We have previously demonstrated
that tetrandrine induces apoptosis at high concentrations
and stimulates autophagy at low concentrations in human
HCC cells, and shows synergistic antitumour effects in
combination with other chemotherapy agents [29-31].
In this study, we found that tetrandrine is a broad-
spectrum potent autophagy agonist with effects on a
variety of cell lines, including cancerous cells and non-
tumorigenic cells. Tetrandrine exhibits a much stronger
activity in inducing autophagy than rapamycin. More-
over, our data show that the accumulation of intracellu-
lar reactive oxygen species (ROS) plays a critical role in
tetrandrine-induced autophagy.
Results
Low-dose tetrandrine does not affect cell viability
We previously demonstrated that 30 μM tetrandrine in-
duced HCC cell apoptosis [29]. In contrast, 5 μM tetran-
drine was sufficient to induce autophagy of liver cancer
cells [30]. To determine whether tetrandrine would
affect cell viability at the dose necessary for triggering
autophagy, we treated MDA-MB-231, MCF-7, Hela and
HFF cells with 10 μM tetrandrine for 24 hours and then
assayed cell viability. We used rapamycin, a well-known
inhibitor of the PI3K-mTOR pathway and autophagy in-
ducer, as a control. As shown in Figure 1, 10 μM tetran-
drine and 50nM rapamycin had almost no effect on cell
survival in both nontumorigenic cell line HFF and tumor
cell lines MDA-MB-231, MCF-7, Hela. Therefore, these
results suggested that this low concentration of tetran-
drine was nontoxic to cells.
Tetrandrine potently induces autophagy in a variety of
cell lines
Although we had recently reported that tetrandrine in-
duces HCC autophagy, it is still unclear whether tetran-
drine can induce autophagy in other cells, such as
cancer cells and nontumorigenic cells. We treated MCF-
7, Hela and HFF cells with increasing concentrations
of tetrandrine for 24 hours and then examined the ex-
pression of LC3-II, a membrane bound form of LC3 and
an established marker of cell autophagy, via western blot
analysis. As shown in Figure 2A, LC3-II protein level
gradually increased in a dose-dependent manner with
tetrandrine treatment. Similarly, tetrandrine induced au-
tophagy of cells in a time-dependent pattern (Figure 2B).
The above results indicated that treating cells with
2.5 μM tetrandrine for 12 hours can effectively induce
autophagy. Further examination showed that tetrandrine
also potently triggers autophagy in other cells, including
PC3, U87, MDA-MB-231, A549 and HEK293. Moreover,treating cells with 2.5 μM tetrandrine and 50 nM rapa-
mycin for 12 hours shown tetrandrine is a much stron-
ger autophagy inducer than rapamycin (Figure 2C), and
staining Hela, MCF-7 and HFF cells with acridine orange
resulted in the formation of numerous acidic autophago-
lysosome vacuoles (AVOs) (Figure 2D). The formation
of punctate spots with GFP-LC3 fusion protein is a well-
characterized marker for visualizing autophagosomes.
Here, we also observed the characteristic punctate fluor-
escent pattern of LC3-GFP when Hela, MCF-7 and HFF
cells were transfected with the LC3-GFP plasmid and
then treated with tetrandrine for 24 hours (Figure 2E).
Collectively, these results suggest that tetrandrine is a
potent autophagy inducer in a variety of cell lines.
3-methyladenine (3-MA) or chloroquine (CQ) blocked
tetrandrine-induced autophagy
To further confirm our findings, we pretreated cells with
3-methyladenine (3-MA), a pan-PI3K inhibitor, for 1 hour
before treatment with tetrandrine. The results showed
that 3-MA partially blocked the formation of autophagoly-
sosome vacuoles and inhibited the LC3-II levels that
tetrandrine induced in MCF-7 and HFF cells by compare
between tetrandrine add 3-MA group and tetrandrine
alone group (Figure 3A and B). Chloroquine (CQ) is an
inhibitor of autophagy flux that prevents autophagosome-
lysosome fusion and lysosomal protein degradation by
raising the lysosomal pH in the latter phase. As shown
in Figure 3C, we found that chloroquine maintains the
LC3-II, p62 and Cathepsin D (CTSD) protein levels and
prevents their degradation by the lysosome compare to
tetrandrine treated only, providing further validation that
the tetrandrine-treated cells underwent autophagy.
Tetrandrine triggered the induction of mitophagy
During autophagy, damaged organelles, such as mito-
chondria, can be engulfed by the double-membraned
autophagosome before fusion with lysosomes, resulting
in mitochondrial autophagy (mitophagy) [32]. To deter-
mine whether tetrandrine-induced autophagy involves
mitophagy, we stained GFP-LC3-overexpressing Hela,
MCF-7 and HFF cells with the MitoTracker Red dye and
observed them by confocal microscopy. The results dem-
onstrated that, when cells were treated with tetrandrine,
autophagy been induced, then green punctae of GFP-LC3
and red light points of MitoTracker co-localized, indicat-
ing that cells underwent mitophagy (Figure 4). These find-
ings suggested that tetrandrine triggered the induction
of mitophagy.
Intracellular reactive oxygen species (ROS) are essential in
tetrandrine-induced autophagy
Cellular accumulation of ROS plays a vital role in the
stimulation of autophagy under conditions of nutrient
Figure 1 Low-dose tetrandrine does not affect cell viability. Data are representative of values from at least three independent experiments.
The MDA-MB-231, MCF-7, and Hela cancer cells, as well as immortalized nonmalignant cells HFF, were treated with rapamycin or tetrandrine alone
for 24 hours. Cells were then counted using a hemocytometer with trypan blue staining. Cell viability was calculated based on the proportion of
cells without trypan blue staining compared to the total number of cells. DMSO treatment was used as a control.
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acute burst of ROS in mitochondria often leads to mito-
chondrial depolarization that then induces mitophagy.
We next investigated whether tetrandrine-induced au-
tophagy was associated with the production of ROS in
Hela and MCF-7 cells. As shown as in Figure 5A and B,
tetrandrine promoted a significant increase in intracellu-
lar ROS in a treatment time-dependent manner, and this
increase was completely blocked by pretreatment with the
reactive oxygen species scavenger N-acetyl- L-cysteine
(NAC). Moreover, the ROS scavenger NAC could almost
completely eliminate the ability of tetrandrine to induce
autophagy, decreased the LC3-II levels and blocked the
formation of green punctae of GFP-LC3 (Figure 5C and
D), which suggests that the activation of intracellular ROS
plays an essential role in tetrandrine-induced autophagy.
Discussion
Exposure to cancer treatments (e.g., chemotherapy, radio-
therapy, hormone therapy and targeted therapy), subjects
cells to stress, which often induces cell autophagy [33,34].
For cancer cells, autophagy serves a dual role, with both
tumor-suppressing and tumor-promoting effects, by regu-
lating cellular homeostasis [35]. Autophagy can become
cytotoxic and lead to cell death if the stress imposed is toosevere or prolonged [36,37]. Therefore, cell autophagy ag-
onists can potentially enhance the efficacy of cancer ther-
apy and be used clinically in cancer treatment. In the
present study, we demonstrated that tetrandrine is a
broad-spectrum potent autophagy agonist exhibiting a
stronger ability to induce cell autophagy than rapamy-
cin that it can potently induce autophagy in a variety of
cell lines, including cancerous cells and nontumorigenic
cells, but the role underlie the effects on autophagy we
still unknown. We previously reported that low doses of
tetrandrine show good synergistic antitumor effects in
combination with other chemotherapeutic agents, but
has no cytotoxicity on normal cells [31]. Combined with
our previous reports of the antitumor effects of tetran-
drine, we speculated that tetrandrine may be a promis-
ing clinical cancer chemotherapeutic agent when used
either alone or in combination with other drugs.
In response to chemotherapeutic drugs or radiation,
sensitive cancer cells will eventually undergo different
forms of death, including apoptosis, autophagic cell death,
necrosis and senescence [36,38]. Some researchers dem-
onstrated that autophagy is often a prelude to many other
forms of death. Different functions of autophagy occur in
response to external stress [39]. Multiple regulatory genes


































































































Figure 2 (See legend on next page.)
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Figure 2 Tetrandrine potently induces autophagy in a variety of cell lines. Western blot analysis of autophagy-related LC3 proteins in Hela,
MCF-7 and HFF cells after treatment with various concentrations (A) and gradient times (B) as indicated. (C) Cells described in the Materials and
Methods section were treated with rapamycin or tetrandrine alone for 24 hours. Autophagy-related LC3 proteins were analyzed by western blot
to assess autophagy induction. (D) Treatment with 5 μM tetrandrine induces autophagy in Hela, MCF-7 and HFF cells as analyzed by the acridine orange
staining assays described in the Materials and Methods section. AO fluorescence was observed with a fluorescence microscope. (E) Cells with GFP-LC3 dots
accumulation exhibited autophagy after tetrandrine treatment and were viewed by confocal microscopy, Error bars represent ± SD, **p < 0.01.
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Here, our studies showed that a low dose of tetrandrine
did not affect cell proliferation and survival. However,
at high concentrations, tetrandrine induces cancer cells
apoptosis. Moreover, tetrandrine-induced autophagy is as-
sociated with the activation intracellular reactive oxygen
species in a variety of cancer cells. It is worth mention
that we used both effective methods to analyze autophagy
including acid lysosome-autophagosome detection and
quantification by acridine orange staining assays and LC3-
II protein level analysis by western blot. Since acridine
orange staining assays by fluorescent microscopy is less
sensitive than western blot protein detection, the lysosome-
autophagosome quantitative measurement showed slightly
different from LC3-II protein level is normal under the
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Figure 3 3-methyladenine (3-MA) or chloroquine (CQ) blocked tetran
cells treated with tetrandrine by acridine orange staining assays after a 1-hour
(B)Western blot analysis of LC3-II protein levels before treatment or in the ab
of LC3-II, p62 and CTSD protein levels treated with tetrandrine for 24 hours afAlmost all types of anticancer agents, such as DNA
damaging agents, antimetabolites, death receptor ago-
nists, hormonal agents, antiangiogenic agents, prote-
asome inhibitors, histone deacetylase inhibitors, and
some kinase inhibitors, have been shown to affect cell
autophagy [33,34]. Although the molecular mechanisms
of autophagy are complex and numerous reports have
reported conflicting roles for autophagy in cancer ther-
apy, most researchers believe that autophagy might
be a potential therapeutic target in cancer treatment
[9,10,42]. In this sense, potent autophagy agonists or in-
hibitors with minimal toxicity are promising candidates
for developing effective anticancer drugs [12,13]. Tet-
randrine is a traditional Chinese medicine that has been
broadly used for thousands of years in China, making it
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drine-induced autophagy. (A) Autophagy analysis in MCF-7 and HFF
pretreatment with 1.5 mM 3-MA. Error bars represent ± SD, **p < 0.01.
sence of 1.5 mM 3-MA in MCF-7 and HFF cells. (C) Western blot analysis










Figure 4 Tetrandrine triggered induction of mitophagy. Mitophagy was detected in GFP-LC3 expressing HFF, Hela and MCF-7 cells treated
with 5 μM tetrandrine for 24 h by labeling with the MitoTracker Red dye and observing under a confocal microscope.
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an autophagy agonist in many systems.
Conclusions
In summary, we present tetrandrine as a potent cell au-
tophagy agonist for many types of cancer cells. It may
have a wide range of applications in the fields of antitu-
mor therapy and basic scientific research.
Material and methods
Chemical reagents and antibodies
Tetrandrine was purchased from Shanghai Ronghe
Medical, Inc. (Shanghai, China) and dissolved in DMSO
for use. DCFH-DA was obtained from Invitrogen
(Carlsbad, CA). 3-Methyladenine (3-MA) and N-acetyl-
L-cysteine were purchased from Sigma (St. Louis, MO).
Acridine orange (AO), GAPDH antibody and HRP-
conjugated secondary antibodies (goat anti-rabbit and goat
anti-mouse) were purchased from Beyotime (Nantong,
China). The antibody against microtubule-associated pro-
tein 1 light chain 3 (LC3) was purchased from Sigma (St.
Louis, MO). The p62 antibody was obtained from Cell
Signaling Technologies (Beverly, MA), and cathepsin D
(CTSD) was acquired from Proteintech Group, Inc.
(Chicago, IL).
Cell lines and cell culture
The non-small-cell carcinoma cell line A549 and
human prostate cancer cell line PC3 were cultured in
complete1640 RPMI medium. The breast cancer cell
lines MCF-7 and MDA-MB-231, glioma cell line U87,
cervical cancer cell line Hela and immortalized nonma-
lignant cell line 293 T were cultured in Dulbecco’s
modified Eagle’s medium (DMEM), and human foreskin
fibroblast HFF were cultured in α-MEM medium
(Gibco BRL, Grand Island, NY, USA); these media were
supplemented with 10% fetal bovine serum (FBS,Hyclone), 1% penicillin and 1% streptomycin. Cells were
cultured at 37°C in a humidified atmosphere of 95%
air and 5% CO2. Cell culture dishes and plates were
obtained from Wuxi NEST Biotechnology (Co., Ltd).
Cell viability analysis
For cell viability assays, cells were observed using the try-
pan blue dye-exclusion assay. Cells were plated on 24-well
plates and incubated with rapamycin or tetradrine for 24 h
before being counted using a hemocytometer with trypan
blue staining. After cells were harvested, cells were rinsed
with PBS and then resuspended in 1 ml of PBS. A 10 μl
aliquot of cell suspension was incubated with 10 μl 0.4%
trypan blue solution for 5 minutes at room temperature.
Viable and nonviable cells based on absence and presence
of intracellular trypan blue dye, respectively. Percentages
were counted by hemacytometer [44].
Western blot analysis
After cells were harvested and lysed in 1% SDS on ice, cell
lysates were immediately heated at 95°C for 15–20 minutes
and then centrifuged at 12,000 × g for 10 minutes. The
supernatant was collected, and the protein concentration
was determined by the Pierce BCA Protein Assay Kit
(Thermo Scientific). Equivalent amounts of protein (20 μg)
from each sample were loaded and run on SDS-PAGE gels
(Amresco), and then transferred to PVDF membranes
(Millipore). After blocking the membranes with 5% non-fat
milk (Bio-Rad) in Tris-buffered saline with 0.1% Tween-20
(TBST) at room temperature for 1 hour, the membranes
were incubated with specific primary antibodies at 4°C
overnight, washed with TBST three times (10 minutes each
time), and incubated with HRP-conjugated secondary anti-
bodies for 1 hour at room temperature. After washing with
TBST, the immunoblots were visualized by chemilumines-
cence using a HRP substrate (Millipore). GAPDH was
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Figure 5 ROS are essential in tetrandrine-induced autophagy. (A) Intracellular ROS accumulation levels measured by flow cytometry after
tetradrine treatment for the indicated times in Hela and MCF-7 cells. (B) Hela and MCF-7 cells were pretreated with 15 mM NAC for 1 hour and
then with tetrandrine for 24 hours. Intracellular ROS levels were measured by flow cytometry. Autophagy detected by western blot analysis of
LC3 levels (C) and GFP-LC3 dots accumulation assay (D) in cells pretreated with NAC, ** p < 0.01.
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After tetradrine treatment, cells stained with acridine
orange for acid lysosome-autophagosome were detected
and quantified by fluorescent microscopy. In this assay,
the intensity of the red fluorescence is proportional to
the degree of acidity. Cells were collected, and the cells
were resuspended in PBS and stained with AO (10 μg/ml)
for 15 min at room temperature [45]. After washing with
PBS, cells resuspended in 0.4 mL PBS, and the fluores-
cence of AO was viewed under a fluorescent microscope
(Leica Microsystems GmbH). AVOs were accumulated in
acidic spaces and fluoresces bright red punctuate staining
dots in cytoplasm.
Measurement of ROS accumulation
The intracellular ROS levels were detected using the
DCFH-DA probe (Sigma) by flow cytometry. Dichloroflu
orescein (DCFH), which has served as the workhorse for
the redox biology community, detects multiple types of
reactive small molecules [46]. Briefly, cells were harvestedafter treatment and washed twice with PBS, incubated with
DCFH-DA (1 μM) in serum-free 1640 at 37°C in a 5% CO2
incubator for 20 minutes, washed twice with PBS and ana-
lyzed by flow cytometry. The data were processed using the
FlowJo software (Tree Star, San Carlos, CA, USA).
Transient transfection and autophagy detection
Cells were seeded on coverslips in 12-well plates. After
12 hours of growth, cells were transiently transfected
with the pEGFP-LC3 plasmid according to the protocol.
Twenty-four hours later, the cells were treated with tetran-
drine. After treatment for 12 hours, the cells were viewed
under a fluorescent microscope (Olympus BX51). The per-
centage of cells with more than five GFP-LC3 dots, which
were considered to be autophagic, was quantified [47].
Mitophagy detection
To detect mitophagy in cells [48], cells transiently trans-
fected with the pEGFP-LC3 plasmid were treated with
tetrandrine for 12 hours. Mito-tracker Red Dye was then
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an hour. Cells were then observed with a confocal fluor-
escent microscope.
Statistical analysis
Results were expressed as the mean ± standard deviation
(SD), and all statistical analyses were performed using
Student’s t- test (two-tailed, unpaired). A P-value of 0.05
or less was considered significant.
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